HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intravenous effects of pimaricin on mycotic endophthalmitis.

Abstract
Rabbits weighing 2 to 3 kg with induced Candida endophthalmitis in the left eye were given 5 mg/kg and 10 mg/kg pimaricin intravenously. In the course of investigation, no significant level of pimaricin was found in the vitreous of those animals receiving 5 to 10 mg/kg pimaricin intravenously, and only 3 microgram/ml aqueous was found after chronic therapy for 1 to 3 weeks. No ocular or retinotoxicity was noted, although toxicity was inherent in the liver, kidney, and endocrine glands. From these studies, it is concluded that intravenous therapy alone is not sufficient for treatment of fungal endophthalmitis due to high toxicity and inadequate ocular drug levels.
AuthorsA C Ellison
JournalAnnals of ophthalmology (Ann Ophthalmol) Vol. 11 Issue 2 Pg. 157-64 (Feb 1979) ISSN: 0003-4886 [Print] United States
PMID312049 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Natamycin
Topics
  • Animals
  • Aqueous Humor (analysis)
  • Candidiasis (blood, drug therapy)
  • Electroretinography
  • Endophthalmitis (blood, drug therapy)
  • Injections, Intravenous
  • Kinetics
  • Natamycin (analysis, therapeutic use, toxicity)
  • Rabbits
  • Vitreous Body (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: